Who gets included? Equity in digital and decentralised mental health and neurodevelopmental trials: A systematic review

Decentralised clinical trials (DCTs) may help address underrepresentation in digital mental health research, but their effectiveness in reaching underserved populations is unclear. This review assessed the reporting of equity-relevant demographic data in DCTs to identify groups at risk of exclusion and barriers and facilitators to inclusive participation. A systematic search was conducted in MEDLINE, PsycINFO, Embase, CINAHL, Cochrane Central Register of Controlled Trials, and Web of Science. We included studies reporting on mental health interventions evaluated via remote, online, virtual, or hybrid DCTs, published in English from 2020-2026 (last search date: 01/07/2025), that reported participant demographics. Demographic data were extracted and summarised according to the PROGRESS-Plus framework. Demographic frequencies were compared to national population statistics. Thematic analysis identified barriers and enablers to inclusive participation in DCTs. Fifty-nine papers reporting 57 DCTs were included. Studies involved a range of mental health and neurodevelopmental conditions across the ages. Gender (100%) and age (100%) were universally reported. Reporting of other PROGRESS-Plus variables across the 57 DCTs was limited: social capital (43.9%); race/ethnicity (40.4%); occupation (36.8%); socioeconomic status (35.1%); place of residence (12.3%); religion (5.3%), and non-mental health disability (1.8%). Participants from ethnic minority backgrounds, males, unemployed individuals, and those with lower educational attainment were consistently underrepresented. While rural populations were better represented in Australian studies, data on poverty, religion, and social capital were limited and varied in representativeness. Most studies focused on adults aged 18–50 years. Thematic analysis identified key barriers including, digital exclusion, low digital literacy, cognitive and sensory challenges. Facilitators included therapist or navigator support and simplified onboarding. Equity variables are persistently underreported. DCTs do not effectively engage underserved populations in mental health research, meaning digital interventions are evaluated on unrepresentative samples. This risks perpetuating, and exacerbating, existing health inequalities, limiting the real-world impact of digital mental health solutions.Author summary: Decentralised clinical trials (DCTs), where research processes happen remotely, often online rather than in clinics, are promoted as a way to widen access to mental health research. We reviewed 57 DCTs focused on mental health and neurodevelopmental conditions to understand who is included in these studies and how well key demographic information is reported. Although age and gender were consistently documented, other important factors, such as ethnicity, socioeconomic status, education, and disability, were frequently missing and represented a source of exclusion. Many trials required reliable internet, specific devices, or digital skills, which may exclude people most affected by digital disadvantage. While DCTs have potential to improve inclusion, more consistent reporting and better consideration of equality, diversity and inclusion (EDI) characteristics, including digital access are needed to ensure these trials truly reach diverse populations.